Skip to main content
. 2020 Apr 29;5(8):1139–1148. doi: 10.1016/j.ekir.2020.04.018

Figure 3.

Figure 3

Approach to immune checkpoint inhibitor (ICI) nephrotoxicity and rechallenge. AIN, acute interstitial nephritis; AKI, acute kidney injury; ATN, acute tubular necrosis; CRP, C-reactive protein; GN, glomerulonephritis; iRAE, immune-related adverse event; RBC, red blood cell; RTA, renal tubular acidosis; UA, urinalysis; WBC, white blood cell.